O.P.S
O.P.S. Oncology Precision System
Transforming the Future of Cancer Treatment with Precision Medicine
Why Choose OPS?
- Precision and Personalization:
OPS leverages artificial intelligence to deliver the best treatment based on each patient’s unique profile.
- Clinically Proven:
Validated in multiple hospitals, showing proven results for breast cancer treatment.
- Improved Quality of Life:
Personalized treatments minimize side effects and enhance atients’ quality of life.
Contact Us for a Free Demonstration
What is OPS?
OPS (Oncology Precision System) is a precision medicine platform powered by artificial intelligence. It analyzes genetic, molecular, and clinical data to provide personalized treatment recommendations.
The platform assists oncologists in making data-driven decisions, improving survival rates and enhancing patients’ quality of life.
Key Benefits of OPS
- 1. Advanced Treatment Personalization
OPS uses AI to recommend the most suitable treatment based on the patient’s profile.
- 2. Proven Efficacy
With 89% accuracy in treatment recommendations, OPS has demonstrated improved 5-year survival rates in breast cancer cases.
- 3. Integration of Critical Biomarkers
OPS incorporates over 112 genetic and molecular biomarkers to identify key mutations that affect treatment responses.
- 4. Reduction in Side Effects
Al ajustar el tratamiento según las características del tumor y el paciente, OPS minimiza los efectos secundarios, mejorando la experiencia del tratamiento.
Advantages for Hospitals and Clinics
Enhanced Diagnostic and Therapeutic Precision
Reduces uncertainty in treatment selection and improves quality of care.
Resource Optimization
Ensures more effective use of medical resources.
Simple Integration
OPS seamlessly integrates with existing hospital systems and offers automatic updates to stay at the forefront of technological advancements.
SaaS Licensing Options
- Annual License:
Unlimited access to the platform for hospital use.
- Per-Patient License:
Designed for clinics and centers with lower patient volumes.
